Search

everythinglearnresearchcommunity

for

Search:↓

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

New medications could improve treatment for severe alopecia areata in Australia.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Aminopterin strongly suppresses epithelial tissues and can treat certain skin conditions but has significant side effects.

Combining topical delgocitinib with a 308-nm excimer laser can effectively treat severe alopecia areata and vitiligo.

Genetically repaired stem cells may treat certain genetic diseases, Th17 cells are key in fighting systemic fungal infections, hair loss in AGA is due to progenitor cell loss, and α-synuclein transfer might contribute to Parkinson's disease progression.

2h-ICPR can help screen for insulin antibodies in type 2 diabetes patients.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Infrared light might help treat stubborn alopecia areata.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

JAK inhibitors are effective for severe alopecia areata but need better strategies for long-term use and personalized treatment.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

HGF/SF injections can stimulate hair growth and increase hair follicle size in mice.

Oral prednisolone helps hair regrowth in alopecia areata.

Baricitinib significantly improves nail and hair symptoms in severe alopecia areata.

Targeting Vδ1+T-cells may help treat alopecia areata.

More frequent PRP sessions with shorter intervals improve hair loss treatment.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

Both LNG-IUD and systemic progestins are effective for fertility-sparing treatment, but close monitoring is needed due to recurrence risk.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Combining PRP with other treatments can improve hair loss outcomes.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.